Home> Products> weve outlined

{ "products": [ { "_id": "6a952f8fed078617ad2e762a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Palmitoylethanolamide,Parsley Extract & Multivitamin Tablets", "description": "What Are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets?\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets are a combination of nutritional supplements formulated with **palmitoylethanolamide (PEA), parsley extract, vitamins, and minerals**. The precise ingredients and quantities can differ between products, so the product label should always be checked for the exact composition and recommended serving.\n\nEach component has a different nutritional or biological role. **Palmitoylethanolamide (PEA)** is a naturally occurring fatty-acid amide that has been researched for its potential contribution to pain-related and inflammatory processes. Clinical research has shown particular interest in PEA for pain-management outcomes, especially when specific formulations such as micronized or ultramicronized PEA are used.\n\n**Parsley extract**, obtained from *Petroselinum crispum*, contains naturally occurring plant compounds, including flavonoids and phenolic constituents. Research has identified compounds such as apigenin and apiin in parsley and has demonstrated antioxidant activity in experimental settings. However, laboratory antioxidant activity should not be interpreted as proof that parsley extract prevents or treats a particular disease.\n\nThe multivitamin component supplies selected vitamins and minerals that contribute to normal nutritional requirements. Such supplements can be useful when dietary intake does not provide adequate amounts of particular nutrients, but they are intended to complement rather than replace a balanced diet.\n\nHow Do Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets Work?\n\nThe combination works through the individual characteristics of its principal ingredients rather than through a single mechanism.\n\n1. Palmitoylethanolamide\n\nPalmitoylethanolamide (PEA) is an endogenous lipid compound found naturally in the body. It has been investigated for its potential analgesic, anti-inflammatory, and neuroprotective activities.\n\nClinical research has examined PEA in various pain-related and neurological settings. Evidence from randomized controlled trials has been particularly promising for pain-related outcomes. However, different PEA products can contain different formulations, and results from one preparation should not automatically be applied to every PEA supplement.\n\n 2. Parsley Extract\n\nParsley contains several naturally occurring phytochemicals, including flavonoids and phenolic compounds. These substances have demonstrated antioxidant properties in experimental research.\n\nThe presence of parsley extract therefore adds a plant-derived nutritional component to the formulation. However, human evidence remains more limited than laboratory research, so claims about disease prevention or treatment should be avoided unless supported by appropriate clinical evidence.\n\n3. Vitamins and Minerals\n\nThe multivitamin portion is designed to provide selected micronutrients that contribute to normal body functions. Vitamins and minerals participate in numerous physiological processes, including energy metabolism, immune function, nervous-system function, and maintenance of tissues.\n\nThe actual nutritional contribution depends on which vitamins and minerals are included and their quantities per tablet or serving.\n\nPotential Benefits of Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets\n\nThe potential benefits of this combination depend on its exact formulation and the nutritional requirements of the individual.\n\nSupport for Pain-Management Strategies\n\nPEA is the component in this combination with the most relevant clinical research. Studies have evaluated PEA as a complementary nutritional approach in different pain conditions, with evidence showing particular interest in pain-related outcomes.\n\nHowever, the presence of PEA does not mean that every PEA-containing supplement is clinically proven to treat chronic pain, neuropathy, or other medical disorders.\n\nNutritional Support\n\nThe vitamin and mineral component can help increase nutrient intake when normal dietary consumption is inadequate.\n\nPeople with restricted diets, reduced food intake, or specific nutritional gaps may sometimes benefit from supplementation. However, supplements are not intended to replace a varied and nutritionally balanced diet.\n\nAntioxidant Nutritional Support\n\nParsley provides naturally occurring flavonoids and phenolic compounds that demonstrate antioxidant activity in experimental research.\n\nThese properties make parsley an interesting botanical ingredient in nutritional formulations, although laboratory findings do not necessarily establish a specific clinical benefit in humans.\n\nConvenient Combination Formula\n\nA combination tablet can offer convenience by bringing PEA, parsley extract, vitamins, and minerals together in one formulation.\n\nConsumers should focus on the actual quantities provided per tablet rather than simply the number of ingredients listed on the packaging.\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets: Uses\n\nDepending on the specific product formulation and labeling, these tablets may be used as a nutritional supplement to\n\n* Support daily nutritional intake\n* Provide selected vitamins and minerals\n* Supply palmitoylethanolamide as part of a complementary wellness or pain-management approach\n* Provide naturally occurring compounds from parsley extract\n* Complement overall nutritional and antioxidant intake\n\nThese supplements should not be promoted as guaranteed treatments or cures for neuropathy, arthritis, inflammation, nerve injury, or other medical diseases.\n\n How to Select the Right Product\n\n 1. Check the PEA Quantity\n\nReview the label to determine the actual amount of **palmitoylethanolamide per tablet or daily serving**.\n\n 2. Consider the PEA Formulation\n\nDifferent clinical studies have evaluated different PEA preparations. Micronized, ultramicronized, and water-dispersible forms have received particular attention in clinical research.\n\n3. Review the Vitamin and Mineral Profile\n\nExamine the complete nutritional panel rather than assuming all multivitamin formulations contain the same nutrients and quantities.\n\n4. Avoid Nutrient Duplication\n\nIf you already use a multivitamin or individual supplements containing nutrients such as vitamin A, iron, zinc, or other minerals, compare the total daily intake to avoid unnecessary excess.\n\n 5. Check Product Information\n\nLook for transparent labeling, manufacturer details, batch information, expiry information, and appropriate quality-control details.\n\n 6. Choose According to Individual Requirements\n\nA product containing more ingredients or higher quantities is not necessarily more beneficial. Selection should be based on individual nutritional requirements and professional guidance when necessary.\n\nPossible Side Effects and Safety\n\nDietary supplements are generally well tolerated when appropriately formulated and used according to directions, but adverse effects and interactions can occur.\n\nPossible problems may include:\n\n* Nausea\n* Stomach discomfort\n* Changes in bowel habits\n* Headache\n* Sensitivity or allergic reactions to individual ingredients\n* Excessive intake of particular vitamins or minerals\n\nThe exact safety profile depends on the complete ingredient list and quantities in the individual product.\n\nPeople who take prescription medicines, have significant medical conditions, are pregnant or breastfeeding, or are preparing for surgery should discuss supplementation with a qualified healthcare professional.\n\nWho Should Use Extra Caution?\n\nAdditional care may be appropriate for individuals who:\n\n* Take several nutritional supplements\n* Regularly use prescription medicines\n* Have an existing medical condition\n* Are pregnant or breastfeeding\n* Have an allergy or sensitivity to an ingredient\n* Are preparing for surgery\n* Are considering supplementation for persistent or unexplained pain\n\nMultivitamins should also not be used as a substitute for a consistently varied diet.\n\nFrequently Asked Questions\n\n1. What are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets used for?\n\nThey are combination nutritional supplements containing PEA, parsley extract, vitamins, and minerals. Depending on the formulation, they may provide nutritional support and PEA as a complementary component of a wellness or pain-management approach.\n\n2. What are the main benefits of these tablets?\n\nPotential benefits depend on the formulation. PEA has been clinically studied mainly for pain-related outcomes; parsley provides naturally occurring plant compounds; and vitamins and minerals help support nutritional intake when dietary consumption is insufficient.\n\n3. Can Palmitoylethanolamide help with nerve pain?\n\nPEA has been investigated in several pain-related and neurological conditions, with clinical research showing promising findings for some pain outcomes. However, it should not automatically be considered a proven treatment for every type of nerve pain or neuropathy.\n\n4. Are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets safe?\n\nSafety depends on the ingredients, quantities, individual health status, and medicines being used. Most appropriately used basic nutritional supplements are tolerated by many people, but excessive nutrient intake and interactions can occur.\n\n5. What side effects can these tablets cause?\n\nPotential effects can include stomach discomfort, nausea, bowel changes, headache, or sensitivity to an ingredient. The exact side effects depend on the complete formulation.\n\n6. Can these tablets be taken with another multivitamin?\n\nCombining multivitamins should be approached carefully because overlapping ingredients can result in excessive intake of certain vitamins or minerals. Compare both labels before combining supplements.\n\n7. How should I choose palmitoylethanolamide tablets?\n\nCheck the PEA quantity, formulation, parsley extract amount, complete vitamin and mineral profile, serving instructions, manufacturer information, and product quality details.\n\n8. Can these tablets replace prescribed pain medicines?\n\nNo. A nutritional supplement should not automatically replace prescribed medication or professional medical care. Persistent, severe, worsening, or unexplained pain should be evaluated appropriately.\n\n9. Do multivitamins provide long-term health benefits?\n\nMultivitamins can increase nutrient intake when dietary intake is inadequate, but this does not mean they universally prevent chronic diseases or extend lifespan in healthy individuals.\n\n10. Can I take these tablets every day?\n\nFollow the dosage or serving instructions provided for the specific product. Taking more than the recommended amount does not necessarily provide greater benefits and may increase the risk of excessive nutrient intake.\n\nConclusion\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets** combine **PEA, parsley extract, vitamins, and minerals** into a single nutritional formulation. PEA is the component with the most relevant clinical research, particularly in relation to pain-related outcomes, while parsley contributes naturally occurring botanical compounds and the multivitamin component supports dietary micronutrient intake.\n\nThe benefits and appropriate use of the combination depend on the exact formulation, ingredient quantities, and individual nutritional requirements. Therefore, consumers should review the complete product label and use the supplement according to its recommended directions.", "price": 579.0, "discountamount": 170.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2499, "imageuri": "https://productimages.withfloats.com/actual/6a952f923833cb5247c5da2d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952f923833cb5247c5da2d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:38:55.369Z", "updatedon": "2026-08-31T07:38:55.369Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/palmitoylethanolamide-parsley-extract-multivitamin-tablets/2499", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PALMI URIDIN 600", "category": "NEUROLOGY RANGE", "tags": [ "Palmitoylethanolamide,Parsley Extract & Multivitamin Tablets", "palmitoylethanolamide", "multivitamin tablets", "best multivitamin tablets", "multivitamin tablets uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a7722af7f45a0190eb37920", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tolperisone Hydrochloride & Paracetamol Tablets", "description": "TOPERITIME P 150/325: Dual-Action Relief for Musculoskeletal Pain and Spasms\nTOPERITIME P 150/325 is a prescription combination therapy formulated to treat acute musculoskeletal discomfort, muscle stiffness, and associated inflammatory pain. By uniting a centrally acting muscle relaxant with a proven analgesic, this film-coated tablet addresses both the neurological and physical aspects of muscle strain, restoring movement and facilitating recovery.\n\nActive Ingredients\nEach film-coated tablet contains:\n\nTolperisone Hydrochloride (150 mg): A muscle relaxant targeting involuntary contractions within the central nervous system.\n\nParacetamol (325 mg): A widely recognized analgesic and antipyretic agent that blocks pain signal transmission.\n\nAvailable in blister packaging and dispensed strictly under a licensed physician's order.\n\nTherapeutic Mechanism\nPainful muscle conditions often create a feedback loop where localized pain triggers involuntary spasms, which in turn exacerbate the pain. TOPERITIME P 150/325 disrupts this cycle through a two-pronged mechanism:\n\nNeuromuscular Regulation: Tolperisone Hydrochloride acts on the spinal cord and brainstem reflexes to inhibit hyperactive nerve impulses driving muscle tension. Unlike traditional skeletal muscle relaxants, it achieves this with minimal central nervous system depression, significantly reducing the likelihood of heavy sedation.\n\nNociceptive Blocking: Paracetamol inhibits prostaglandin synthesis within the central nervous system, raising the body's overall pain threshold and attenuating pain signals originating from injured tissues.\n\nBy simultaneously relaxing tight muscle fibers and dampening pain sensation, the formulation provides comprehensive symptomatic relief.\n\nClinical Indications\nHealthcare professionals may prescribe TOPERITIME P 150/325 for various acute and subacute conditions characterized by pain and hypertonia, including:\n\nAcute muscle spasms and athletic injuries\n\nAcute or chronic lower back pain (lumbago)\n\nCervical spine discomfort and stiff neck\n\nCervical and lumbar spondylosis\n\nFrozen shoulder (adhesive capsulitis)\n\nPost-operative or post-traumatic muscle recovery\n\nGeneralized connective tissue or orthopedic pain\n\nKey Clinical Features\nBalanced Dual Action: Simultaneously targets involuntary contractions and pain sensation.\n\nLow-Sedation Profile: Tolperisone allows patients to maintain daily function without severe daytime drowsiness typical of older relaxants.\n\nEnhanced Mobility: Reduces joint and tissue stiffness, enabling better engagement in physical rehabilitation.\n\nStreamlined Regimen: Combines two therapeutic agents into a single convenient dosage form.\n\nUsage Guidelines\nThis medication must be taken strictly in accordance with a medical prescription.\n\nAdministration: Swallow the tablet whole with water. Do not crush, chew, or split the film-coated tablet.\n\nTiming: Take immediately after a meal to reduce potential gastrointestinal upset, unless directed otherwise by a doctor.\n\nCompliance: Complete the full course prescribed by your physician, and do not alter the recommended dosage.\n\nPotential Side Effects\nWhile generally well-tolerated, some individuals may experience mild side effects, including:\n\nGastrointestinal distress or mild nausea\n\nTransient dizziness or lightheadedness\n\nHeadaches\n\nGeneral fatigue or muscular weakness\n\nRare: Hypersensitivity reactions or cutaneous skin rashes (discontinue use and consult a physician immediately if severe symptoms appear).\n\nSafety Precautions and Considerations\nConsult a medical practitioner prior to initiating treatment if any of the following apply:\n\nPre-existing hepatic (liver) or renal (kidney) impairment\n\nKnown hypersensitivity to Tolperisone, Paracetamol, or related compounds\n\nPregnancy, plans for pregnancy, or active breastfeeding\n\nHistory of chronic alcohol dependency (due to increased liver sensitivity with Paracetamol)\n\nConcurrent use of other medications, particularly other products containing Paracetamol or central nervous system depressants\n\nStorage and Handling\nStore in a cool, dry area below 25°C (77°F).\n\nProtect from direct light, heat, and moisture.\n\nKeep strictly out of reach of children and pets.\n\nCheck the packaging expiration date before administration.\n\nFrequently Asked Questions\nWhat primary conditions does TOPERITIME P 150/325 treat?\n\nIt is indicated for short-term relief from acute musculoskeletal pain, muscle spasms, neck strains, backaches, and related orthopedic disorders.\n\nWhy is Tolperisone combined with Paracetamol?\n\nTolperisone eases muscle tightness at the neurological level, while Paracetamol lowers overall pain perception, creating a synergistic effect that addresses both spasm and pain together.\n\nWill this medication cause severe drowsiness?\n\nTolperisone is specifically designed to exert less sedating activity compared to older muscle relaxants. However, individual sensitivity varies, so caution is advised when driving or operating machinery until individual tolerance is established.\n\nIs TOPERITIME P 150/325 available over the counter?\n\nNo. It requires a valid medical prescription and direct supervision by a registered healthcare professional.", "price": 95.0, "discountamount": 29.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2493, "imageuri": "https://productimages.withfloats.com/actual/6a7722b0ed25653efa18364e.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a7722b0ed25653efa18364e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-08T12:35:59.075Z", "updatedon": "2026-08-08T12:35:59.075Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tolperisone-hydrochloride-paracetamol-tablets/2493", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TOPERITIME P 150/325", "category": "ORTHOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a509bf6f44be736283180cf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gatifloxacin & prednisolone acetate ophthalmic suspension", "description": "Gatifloxacin and prednisolone acetate ophthalmic suspension is a prescription combination eye medicine that pairs a fourth-generation fluoroquinolone antibiotic (gatifloxacin) with a corticosteroid (prednisolone acetate) in a single formulation. It is used to treat steroid-responsive ocular inflammation where there is also a risk of, or existing, bacterial eye infection — most commonly after cataract or other ocular surgery, and in certain inflammatory eye conditions requiring both anti-infective and anti-inflammatory action together. Gatifloxacin fights the bacteria, while prednisolone acetate reduces inflammation, redness, and swelling. This combination is not the same as a plain antibiotic drop — because it contains a steroid, it requires closer monitoring, a defined tapering schedule, and should never be self-prescribed or used beyond the duration your ophthalmologist recommends. It is a Schedule H prescription-only medicine in India, commonly marketed under brand names such as Gatiquin P.\n\nWhat Is Gatifloxacin and Prednisolone Acetate Ophthalmic Suspension?\nGatifloxacin and prednisolone acetate ophthalmic suspension is a fixed-dose combination eye drop that brings together two distinct classes of medication in one bottle:\n\nGatifloxacin — a fourth-generation fluoroquinolone antibiotic effective against a broad range of gram-positive and gram-negative bacteria commonly implicated in ocular infections.\nPrednisolone acetate — a corticosteroid that suppresses inflammation, swelling, and associated redness or discomfort in the eye.\n\nThis combination is typically prescribed when a clinician determines that an eye condition involves both active or potential bacterial infection and significant inflammation — a situation where using either drug alone would be insufficient. The most frequent use case is post-operative care following ocular surgery, such as cataract extraction, where inflammation control speeds recovery while the antibiotic component guards against surgical-site infection.\nA commonly recognized branded version of this combination in the Indian market is Gatiquin P, and patients often search specifically for this brand name alongside the generic combination name.\n\nHow Does This Combination Work? (Mechanism of Action)\n\nAntibacterial action (Gatifloxacin) – Gatifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes bacteria need to replicate their DNA, resulting in bactericidal activity against susceptible organisms.\nAnti-inflammatory action (Prednisolone acetate) – Prednisolone acetate suppresses the inflammatory cascade by inhibiting phospholipase A2 and reducing the release of inflammatory mediators, which decreases swelling, redness, and discomfort.\nCombined surgical/inflammatory coverage – Together, the two components address both the infective and inflammatory components of a single ocular condition, which is particularly useful in the immediate post-surgical period when both risks are elevated simultaneously.\nLocalized ocular delivery – As a topical suspension, the combination acts directly at the site of application, minimizing systemic absorption compared to oral antibiotics or steroids.\n\n\nClinical Indications\nIndicationDetailsPost-operative inflammation with infection riskMost common use — following cataract surgery or other intraocular proceduresSteroid-responsive inflammatory ocular conditionsWhere a bacterial infection is present or risk is significantChronic anterior uveitis with secondary infection riskUsed under specialist supervisionBlepharoconjunctivitis with inflammatory componentWhen combined anti-infective and anti-inflammatory action is clinically indicated\nNot indicated for: viral eye infections (e.g., herpes simplex keratitis), fungal eye infections, mycobacterial infections, or uncomplicated bacterial conjunctivitis without an inflammatory component — a steroid is not appropriate in these settings.\n\nDosage & Administration\nParameterRecommendationStandard dose1–2 drops in the affected eye, typically 4 times daily, or as directedPost-surgical regimenOften started with a higher frequency and gradually tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationDetermined by your ophthalmologist; steroid-containing drops are not for indefinite useTaperingMust be tapered gradually rather than stopped abruptly, especially after prolonged useContact lensesAvoid wearing contact lenses during treatment unless your doctor advises otherwiseMissed doseApply as soon as remembered; do not double the next dose\nImportant: Never extend use beyond the prescribed duration or restart the medication without consulting your ophthalmologist, as prolonged steroid exposure carries specific ocular risks (see Precautions below).\n\nKey Benefits\n\nProvides dual-action therapy — infection control and inflammation control — in a single formulation\nReduces the need for two separate eye drop regimens after surgery, simplifying the treatment schedule\nSpeeds resolution of post-surgical redness, swelling, and discomfort while covering infection risk\nBroad-spectrum antibacterial coverage from a fourth-generation fluoroquinolone\nCommonly trusted and prescribed by ophthalmic surgeons as part of standard post-operative protocols\nAvailable in a suspension formulation designed for effective ocular surface contact time\n\n\nPrecautions\n\nUse strictly under ophthalmologist supervision — this is not an over-the-counter product\nNot suitable for viral, fungal, or mycobacterial eye infections\nLong-term or unsupervised steroid use can raise intraocular pressure (IOP) and increase glaucoma risk\nProlonged use may increase the risk of posterior subcapsular cataract formation\nSteroid component may mask signs of a worsening infection or delay wound healing if misused\nRegular monitoring of intraocular pressure is recommended with extended use\nInform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting\nShake the suspension well before each use for accurate dosing\nAvoid touching the dropper tip to the eye or any surface\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nTransient burning or stinging on instillation\nBlurred vision immediately after application\nEye discomfort or foreign-body sensation\nMild eye redness\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nIncreased intraocular pressure / glaucoma symptoms (eye pain, halos around lights)\nDelayed wound healing at a surgical site\nSecondary or masked ocular infection\nSigns of cataract progression with prolonged use\nCorneal or scleral thinning (rare, with extended steroid exposure)\nAllergic reaction (eyelid swelling, itching, rash)\n\nDiscontinue and consult your ophthalmologist immediately if any serious symptom develops.\n\nComparison: Combination vs. Standalone Therapies\nTreatmentCompositionBest Suited ForKey ConsiderationGatifloxacin + Prednisolone acetate suspensionAntibiotic + steroidPost-surgical care; infection + inflammation togetherRequires tapering; steroid monitoring neededGatifloxacin eye drops (alone)Antibiotic onlyUncomplicated bacterial conjunctivitis/keratitisNo steroid-related risk, but no anti-inflammatory actionPrednisolone acetate eye drops (alone)Steroid onlyNon-infectious inflammatory conditions (e.g., uveitis)Not appropriate if active infection is presentPlain lubricant/antibiotic-only regimensVariesMild post-op cases without significant inflammationMay be insufficient for higher-risk surgical cases\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported post-operative infection rate reduction with prophylactic use[Placeholder – insert verified clinical trial statistic]Typical duration of post-cataract-surgery combination therapy[Placeholder – insert verified reference range]Incidence of steroid-induced IOP elevation with short-course use[Placeholder – insert epidemiological reference]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Gatifloxacin and Prednisolone Acetate Ophthalmic Suspension\nThe price of this combination suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nGatifloxacin and prednisolone acetate ophthalmic suspension serves an important clinical role wherever bacterial infection risk and ocular inflammation occur together — most notably in the sensitive period following eye surgery. By combining a potent fourth-generation antibiotic with a well-established corticosteroid, this formulation streamlines post-operative and steroid-responsive inflammatory care into a single, clinician-directed regimen. Because the steroid component carries specific long-term risks — including elevated eye pressure, cataract progression, and delayed healing if misused — this medication should always be used exactly as prescribed, for the duration recommended, and with appropriate tapering and follow-up. Patients should never self-adjust dosing or extend use without their ophthalmologist's explicit guidance.\n\nFrequently Asked Questions\n\n1. What is Gatifloxacin and prednisolone acetate ophthalmic suspension used for?\nIt is used to treat eye conditions that involve both inflammation and a risk of bacterial infection — most commonly after eye surgery such as cataract surgery, where it reduces post-operative swelling and redness while protecting against infection.\n\n2. Is Gatifloxacin eye drops safe for children?\nGatifloxacin eye drops are generally considered usable in children for appropriate bacterial eye infections under a pediatric ophthalmologist's guidance. However, the gatifloxacin-prednisolone combination includes a steroid, which requires closer specialist supervision in children due to potential effects on eye pressure and healing, so it should only be used if specifically prescribed for a child.\n\n3. What is Gatifloxacin and prednisolone acetate ophthalmic suspension (Gatiquin P) used for?\nGatiquin P is a branded formulation of gatifloxacin and prednisolone acetate ophthalmic suspension. It is used for the same core purpose — managing post-surgical or steroid-responsive ocular inflammation where there is also a bacterial infection risk, most often following cataract or other intraocular surgery.\n\n4. Is prednisolone acetate safe for eyes?\nPrednisolone acetate is a corticosteroid that is generally safe for eyes when used exactly as prescribed and for the recommended duration under an ophthalmologist's supervision. However, unsupervised or prolonged use can raise intraocular pressure, increase glaucoma risk, contribute to cataract formation, and delay wound healing, so it should never be used without medical guidance or beyond the prescribed course.\n\n5. How is this eye drop different from regular antibiotic eye drops?\nRegular antibiotic eye drops only target bacteria, while this combination also contains a steroid to control inflammation. This dual action is useful specifically when both infection risk and significant inflammation are present, such as after eye surgery.\n\n6. How long should I use gatifloxacin and prednisolone acetate suspension?\nDuration is determined by your ophthalmologist based on your specific condition, often following a tapering schedule after surgery. It should not be used longer than prescribed, and stopping should be discussed with your doctor rather than done abruptly.\n\n7. Can this eye drop increase eye pressure?\nYes, because it contains a steroid, prolonged or unsupervised use can raise intraocular pressure. Regular monitoring is recommended, especially with extended use or in patients with a history of glaucoma.\n\n8. Can I use this suspension for a common bacterial eye infection without inflammation?\nThis combination is generally reserved for cases where both infection risk and notable inflammation are present, such as post-surgical care. For uncomplicated bacterial conjunctivitis without significant inflammation, your doctor may prescribe an antibiotic-only formulation instead.\n\n9. Do I need to shake the bottle before use?\nYes. This is a suspension, so the bottle should be shaken well before each use to ensure even distribution of both active ingredients.\n10. Can this eye drop be used for viral or fungal eye infections?\nNo. This combination is not appropriate for viral, fungal, or mycobacterial eye infections, since it contains a steroid that can worsen these conditions if used inappropriately.\n\n11. What are the signs I should stop using this eye drop and see my doctor?\nIncreasing eye pain, blurred vision that doesn't improve, halos around lights, worsening redness, or signs of an allergic reaction warrant immediate medical attention.\n\n12. Can this eye drop be used after cataract surgery?\nYes, this combination is commonly prescribed after cataract surgery to manage post-operative inflammation while covering the risk of surgical-site infection during the healing period.\n\n13. Does this medication require a prescription?\nYes, gatifloxacin and prednisolone acetate ophthalmic suspension is a prescription-only (Schedule H) medicine and should only be used under an ophthalmologist's direction.\n14. Can contact lenses be worn during treatment?\nIt is generally advised to avoid wearing contact lenses while using this medication unless your ophthalmologist specifically advises otherwise, particularly during the post-surgical period.\n\n15. What happens if I stop this eye drop too early?\nStopping too early, especially without proper tapering, may lead to a rebound of inflammation or leave a lingering infection insufficiently treated. Always follow your doctor's full course and tapering instructions.\n\n16. Is this eye drop safe for long-term daily use?\nNo — because it contains a steroid, it is intended for short-term, supervised use rather than long-term daily use. Extended use significantly raises the risk of elevated eye pressure and cataract.\n\n17. Can this suspension be used in both eyes at once?\nIt can be used in both eyes if both are affected and your doctor has prescribed it for bilateral use; otherwise, apply only to the eye(s) specifically directed by your ophthalmologist.\n", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2469, "imageuri": "https://productimages.withfloats.com/actual/6a509bf79c2198e9ddf06962.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a509bf79c2198e9ddf06962.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T07:15:02.084Z", "updatedon": "2026-07-10T07:15:02.084Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gatifloxacin-prednisolone-acetate-ophthalmic-suspension/2469", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION GATIPRED", "category": "Opthalmology Range", "tags": [ "gatifloxacin & prednisolone acetate ophthalmic suspension", "gatifloxacin & prednisolone ophthalmic suspension" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a4cf84af44be73628317db4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ketorolac tromethamine ofloxacin eye drops", "description": "Ketorolac tromethamine ofloxacin eye drops are a prescription combination formulation that pairs an NSAID (ketorolac tromethamine) with a fluoroquinolone antibiotic (ofloxacin) in a single ophthalmic solution. Ketorolac reduces pain, inflammation, and irritation, while ofloxacin treats or prevents bacterial eye infections — making this combination especially useful after eye surgery, such as cataract or corneal refractive procedures, when both inflammation control and infection prevention are needed at the same time. It's generally well tolerated, with mild stinging or burning being the most common effect, and should only be used exactly as prescribed by an eye care professional.\nWhat Is Ketorolac Tromethamine Ofloxacin Eye Drops?\nThis is a fixed-dose combination ophthalmic solution bringing together two distinct classes of medication:\n\nKetorolac tromethamine — a nonsteroidal anti-inflammatory drug (NSAID) that blocks prostaglandin synthesis in the eye, reducing pain, inflammation, and irritation\nOfloxacin — a fluoroquinolone antibiotic that treats bacterial infections of the eye, including conjunctivitis and corneal ulcers, by inhibiting bacterial DNA replication\n\nCombining the two addresses two separate clinical needs at once: controlling post-operative or allergy-related inflammation, and reducing the risk of bacterial infection during the eye's vulnerable healing period. This combination is commonly prescribed following cataract surgery, corneal refractive surgery, and other ocular procedures where both inflammation and infection risk need to be managed together.\nHow This Combination Works (Mechanism of Action)\n\nKetorolac's anti-inflammatory action — Blocks the cyclooxygenase (COX) enzyme pathway, reducing the production of prostaglandins, the chemical messengers responsible for pain, redness, and swelling in the eye.\nReduced pain and irritation — With prostaglandin production suppressed, patients experience less post-surgical discomfort, itching, and burning.\nOfloxacin's antibacterial action — Inhibits bacterial DNA gyrase and topoisomerase IV, enzymes bacteria need to replicate their DNA, effectively stopping bacterial growth.\nInfection prevention/control — By suppressing bacterial replication, ofloxacin helps prevent or treat infections that could otherwise complicate the eye's healing process after surgery or injury.\nCombined post-operative support — Together, the two components address both major risks during ocular recovery: uncontrolled inflammation and secondary bacterial infection.\n\nClinical Indications\nUse CaseRole of the CombinationPost-cataract surgery careControls inflammation and pain while preventing bacterial infection during healingPost-corneal refractive surgery (e.g., LASIK)Reduces post-operative discomfort and infection riskBacterial conjunctivitis with inflammationTreats the underlying infection while easing associated redness and irritationCorneal injury or minor trauma (as directed)Supports healing by addressing both inflammation and infection riskSeasonal allergic conjunctivitis (ketorolac component)Relieves itching associated with seasonal eye allergies\nThis combination is intended for short-term, doctor-directed use — not for long-term or repeated self-administration.\nDosage Guidelines\nParameterTypical GuidanceStandard doseOne drop in the affected eye(s), frequency as prescribed by your doctorCommon frequencyOften 2 to 4 times daily, depending on the condition being treated and product-specific labelingPost-surgical useUsually started shortly after surgery and continued for a defined post-operative period, as directedAdministration techniqueTilt head back, pull down the lower eyelid, instill the drop without touching the dropper tip to the eye, then close the eye gently for a minute or twoContact lens useAvoid wearing contact lenses during treatment unless your doctor says otherwiseDurationComplete the full prescribed course, even if symptoms improve early, to reduce the risk of antibiotic resistance or incomplete healing\nExact dosing frequency and treatment duration vary by brand formulation and the specific condition being treated — always follow your prescribing doctor's exact instructions rather than a generic schedule.\nKey Benefits\n\nAddresses two major post-surgical risks — inflammation/pain and bacterial infection — in a single combination product\nReduces the need for two separate eye drop bottles, simplifying the post-operative care routine\nKetorolac's anti-inflammatory action helps improve comfort during the critical early healing window after eye surgery\nOfloxacin's broad-spectrum antibacterial activity covers many common eye pathogens\nUseful for both surgical recovery and certain inflammatory/infectious conditions like allergic or bacterial conjunctivitis with associated discomfort\n\nPrecautions\n\nShould be used strictly under the guidance of an ophthalmologist — not for self-directed or prolonged use\nDo not use alongside other NSAID eye drops, as this can increase the risk of bleeding and delayed healing\nUse with caution alongside steroid-containing eye drops, as combined use may increase infection risk\nUse with caution in patients who bleed easily or are on blood-thinning medication, due to ketorolac's NSAID effects\nIf symptoms do not improve within the expected timeframe, or worsen, contact your doctor rather than continuing use independently\nAvoid contact lens wear during treatment unless specifically advised otherwise\nDiscontinue immediately and contact your doctor at the first sign of a rash or allergic reaction\nNot recommended for infants under 1 year old (based on the ofloxacin component's approved age range)\n\nSide Effects\nCommon side effects:\n\nStinging or burning on application\nTemporary blurred vision\nEye redness or irritation\nDryness or excess tearing\nSensitivity to light (photophobia)\n\nLess common side effects:\n\nItching or foreign body sensation in the eye\nEyelid swelling\nMild headache\n\nRare but serious side effects — seek immediate medical attention:\n\nSigns of an allergic reaction: hives, difficulty breathing, swelling of the face, lips, tongue, or throat\nSevere skin reaction: fever, sore throat, facial or tongue swelling, skin pain followed by a spreading red or purple rash with blistering\nCorneal problems: persistent eye pain, corneal thinning, erosion, or non-healing of the eye surface\nWorsening infection symptoms despite treatment\n\nMost side effects are mild and temporary; however, any signs of a serious allergic or corneal reaction require prompt medical attention.\nComparison with Alternatives\nFeatureKetorolac + Ofloxacin CombinationSteroid + Antibiotic Combination (e.g., Dexamethasone + Tobramycin)Anti-inflammatory mechanismNSAID (COX inhibition)Corticosteroid (broader immune suppression)Infection risk with prolonged useLower relative infection-masking riskHigher risk of masking infection with prolonged steroid useTypical use casePost-operative pain/inflammation with infection preventionBroader inflammatory eye conditions requiring stronger anti-inflammatory controlIntraocular pressure effectMinimal IOP effect from ketorolacSteroids can raise intraocular pressure with prolonged use\nYour ophthalmologist will select the combination best suited to your specific procedure, condition, and risk factors.\nKey Statistics\n[Placeholder — pending clinical/regulatory team verification. Do not publish without confirmed source citation for post-operative infection rate reduction data, comparative efficacy figures, or incidence rates of reported adverse effects for this specific combination product.]\nExpert Insight\n[Placeholder — reserved for a quote from a qualified ophthalmologist or clinical reviewer. Do not publish without a verified, attributable expert quote.]\nFrequently Asked Questions\n1. What is ketorolac and ofloxacin eye drops used for?\nThis combination is used to control pain, inflammation, and irritation while also preventing or treating bacterial infection in the eye — most commonly after cataract or corneal refractive surgery, and sometimes for infected, inflamed conditions like bacterial conjunctivitis.\n2. Is ketorolac eye drops safe to use?\nKetorolac eye drops are generally safe when used as prescribed by a doctor for approved indications like post-surgical inflammation or allergic conjunctivitis. As with any NSAID, it should be used with caution in people who bleed easily or take blood thinners, and not combined with other NSAID eye drops.\n3. Is ofloxacin safe for eyes?\nYes, ofloxacin eye drops are considered safe and are widely prescribed for bacterial eye infections when used as directed. Common effects are mild and temporary, such as stinging or light sensitivity; serious reactions are rare but should be reported to a doctor immediately if they occur.\n4. Is ketorolac safe for eyes?\nKetorolac eye drops are safe for ophthalmic use when prescribed appropriately and used according to your doctor's instructions. It's an established NSAID with a long history of use for post-surgical pain and allergic conjunctivitis, though it requires caution in certain patients, such as those with bleeding disorders.\n5. How many times a day can you use ketorolac eye drops?\nThis depends on the condition being treated and your doctor's specific prescription — commonly this is 2 to 4 times daily. Always follow your doctor's exact dosing instructions rather than a generic schedule, since frequency varies by indication and product.\n6. Does ketorolac reduce eye pressure?\nNo, ketorolac is not used to reduce intraocular eye pressure. It works as an anti-inflammatory pain reliever by blocking prostaglandin production, not as a pressure-lowering agent. Medications specifically designed to reduce eye pressure, such as those used in glaucoma, work through different mechanisms and are a separate category of treatment.\nConclusion\nKetorolac tromethamine ofloxacin eye drops offer a practical, combined solution for two of the most important concerns during eye recovery: controlling inflammation and pain, and preventing bacterial infection. By pairing an established NSAID with a trusted fluoroquinolone antibiotic, this combination simplifies post-operative care, particularly after cataract or corneal refractive surgery, while addressing allergic and infectious inflammatory conditions when appropriate. Most side effects are mild and temporary, though the combination should always be used exactly as prescribed, with attention to precautions around other eye medications, bleeding risk, and contact lens use. As with any prescription ophthalmic treatment, ongoing follow-up with your ophthalmologist ensures the medication is working as intended and any concerns are addressed early.", "price": 90.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2467, "imageuri": "https://productimages.withfloats.com/actual/6a4cf84ca50a3eb7ed21b13b.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a4cf84ca50a3eb7ed21b13b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-07T12:59:54.142Z", "updatedon": "2026-07-07T12:59:54.142Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ketorolac-tromethamine-ofloxacin-eye-drops/2467", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION KEYPROFEN OFLA", "category": "Opthalmology Range", "tags": [ "ketorolac tromethamine ofloxacin eye drops", "ketorolac tromethamine", "ketorolac tromethamine uses", "ketorolac tromethamine uses in hindi", "ketorolac tromethamine dispersible tablets uses in hindi", "ketorolac tromethamine tablet uses in hindi", "ketorolac tromethamine use in hindi", "ketorolac tromethamine use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a4cf32ff4503514c0b03999", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "tropicamide eye drops ip", "description": "Tropicamide eye drops IP are a prescription ophthalmic solution used to dilate the pupil (mydriasis) and temporarily paralyze the eye's focusing muscles (cycloplegia) before eye examinations and certain ocular procedures. Dilation typically begins within 20–40 minutes of application and lasts around 4–6 hours, though effects can occasionally persist longer. Tropicamide is widely used by ophthalmologists and optometrists to get a clear, detailed view of the retina, optic nerve, and back of the eye — something that isn't possible through an undilated pupil. It's generally well tolerated, though temporary blurred vision and light sensitivity are expected effects rather than side effects to worry about.\nWhat Is Tropicamide Eye Drops IP?\nTropicamide eye drops IP (manufactured to Indian Pharmacopoeia standards) are an anticholinergic (antimuscarinic) ophthalmic solution, commonly available in 0.5% and 1% strengths. “IP” indicates the formulation meets the quality and purity standards set by the Indian Pharmacopoeia.\nTropicamide belongs to the same broad drug family as atropine but has a much shorter duration of action, which is precisely why it's the preferred choice for routine eye examinations — it does its job quickly and wears off within hours rather than days. It's typically administered directly by a healthcare provider in a clinical or hospital setting, rather than self-administered at home.\nHow Tropicamide Works (Mechanism of Action)\n\nMuscarinic receptor blockade — Tropicamide blocks acetylcholine from binding to muscarinic receptors in the eye's iris sphincter and ciliary muscles.\nPupil dilation (mydriasis) — With the sphincter muscle relaxed, the pupil's natural constricting reflex is blocked, allowing it to widen.\nParalysis of accommodation (cycloplegia) — The ciliary muscle, responsible for adjusting eye focus for near vision, is also relaxed, temporarily reducing the eye's ability to focus on close objects.\nClear visualization of the fundus — With the pupil fully dilated, the examining doctor can clearly view the retina, macula, optic nerve, and vitreous — structures that are otherwise obscured behind an undilated pupil.\nNatural wearing-off — As the drug is metabolized and clears from the eye tissue, muscle tone gradually returns, and the pupil returns to its normal size and reactivity.\n\nClinical Indications\nUse CaseWhy Tropicamide Is UsedDilated fundus examinationAllows a detailed view of the retina, optic nerve, and maculaPre- and post-cataract surgeryAchieves adequate pupil dilation for surgical visibility and reduces post-operative inflammation-related discomfortDiagnosis of refractive errors in childrenCycloplegic effect prevents the eye from actively focusing, giving a more accurate refraction measurementRetinal and posterior segment proceduresSupports clear visualization for laser treatments and retinal surgeryEvaluation of optic nerve or cranial nerve abnormalitiesHelps assess disc swelling, cup-to-disc ratio, and pupillary responsesAnterior uveitis management (adjunctive use)Cycloplegic effect can reduce pain and the risk of complications like posterior synechiae\nDosage Guidelines\nParameterTypical GuidanceStandard strength0.5% or 1% ophthalmic solutionTypical doseOne drop instilled into the eye(s), as directed by the examining doctorOnset of actionDilation usually begins within 20–40 minutesDuration of effectCommonly 4–6 hours; can occasionally last longer depending on individual responseAdministration techniqueTilt the head back, pull down the lower eyelid, instill the drop, then close the eye gently for 2–3 minutes without blinking; applying gentle pressure at the inner corner of the eye can help limit systemic absorptionRepeat dosingA second drop may be used after several minutes if dilation is insufficient, at the doctor's discretion\nTropicamide is typically administered by a healthcare professional in a clinical setting rather than self-instilled at home, and dosing should always follow the specific instructions of the treating doctor.\nKey Benefits\n\nProvides fast, reliable pupil dilation, enabling a thorough examination of the back of the eye\nShort duration of action (compared to atropine) means vision and eye function return to normal within hours, not days\nWell-established, widely used mydriatic with a strong long-term safety record in clinical practice\nSupports more accurate diagnosis of refractive errors in children through its cycloplegic effect\nUseful both for routine diagnostic eye exams and as part of pre-/post-surgical eye care\nAvailable in two strengths (0.5% and 1%), allowing the examining doctor to tailor the degree of dilation needed\n\nPrecautions\n\nShould only be administered by, or under the direct guidance of, a qualified eye care professional\nWear sunglasses after application, since dilated pupils let in significantly more light and cause noticeable light sensitivity\nAvoid driving or operating machinery until vision returns to normal, as focusing on nearby objects (like a dashboard or phone) will be impaired\nDo not wear contact lenses during instillation, as the preservative in some formulations can discolor soft lenses\nUse caution in patients with a history of narrow-angle glaucoma, as pupil dilation can rarely trigger a sudden, serious rise in eye pressure (angle-closure glaucoma)\nIn children, wash hands thoroughly after administration, since rare but serious anticholinergic effects (including psychosis) have been reported, particularly with higher doses or accidental ingestion\nInform the doctor of any history of heart conditions, as anticholinergic effects can occasionally affect heart rate\n\nSide Effects\nCommon side effects (expected and temporary):\n\nBlurred vision, especially for near objects\nIncreased sensitivity to light (photophobia)\nMild stinging or burning sensation on application\nTransient increase in intraocular pressure\n\nLess common side effects:\n\nDry mouth\nHeadache\nIncreased heart rate\nFlushing or mild fever\nEye surface irritation\n\nRare but serious side effects — seek immediate medical attention:\n\nSigns of an allergic reaction: hives, difficulty breathing, swelling of the face, lips, tongue, or throat\nConfusion, slurred speech, agitation, or hallucinations (rare anticholinergic toxicity, more often reported in children)\nSudden eye pain, severe headache, nausea, or vomiting (possible signs of angle-closure glaucoma)\n\nMost side effects resolve on their own as the drug wears off within a few hours; however, any signs of a serious reaction should be reported to a doctor right away.\nComparison with Alternatives\nFeatureTropicamideAtropineOnset of action20–40 minutes30–40 minutesDuration of effect4–6 hours (short-acting)Up to 1–2 weeks (long-acting)Common useRoutine diagnostic dilation, fundus examsCycloplegic refraction in select cases, anterior uveitis managementPreferred settingOutpatient eye exams, same-day proceduresCases needing prolonged cycloplegia\nTropicamide's shorter duration makes it the preferred first choice for most routine eye examinations, where rapid return to normal vision is desirable.\nKey Statistics\n[Placeholder — pending clinical/regulatory team verification. Do not publish without confirmed source citation for dilation success rates, comparative onset/duration data, or incidence rates of rare adverse effects.]\nExpert Insight\n[Placeholder — reserved for a quote from a qualified ophthalmologist or clinical reviewer. Do not publish without a verified, attributable expert quote.]\nFrequently Asked Questions\n1. What is tropicamide eye drops used for?\nTropicamide eye drops are used to dilate the pupil and temporarily relax the eye's focusing muscles, allowing an eye doctor to clearly examine the retina, optic nerve, and back of the eye during routine eye exams and certain procedures.\n2. How long does dilation last with tropicamide?\nDilation typically begins within 20–40 minutes and lasts about 4–6 hours, though this can vary slightly from person to person. Vision usually returns to normal well within the same day.\n3. What are the risks of tropicamide eye drops?\nCommon effects include temporary blurred vision and light sensitivity. Less commonly, dry mouth, headache, or a faster heartbeat can occur. Rare but serious risks include an allergic reaction or, in susceptible individuals, a sudden rise in eye pressure (angle-closure glaucoma) — these require immediate medical attention.\n4. What are the benefits of tropicamide?\nTropicamide allows for fast, reliable pupil dilation with a much shorter recovery time than older agents like atropine, enabling accurate diagnosis of retinal and optic nerve conditions while letting patients return to normal vision within hours.\nConclusion\nTropicamide eye drops IP remain one of the most widely used and trusted tools in modern eye care, offering fast-acting, short-duration pupil dilation that allows eye care professionals to thoroughly examine the structures at the back of the eye. Its short window of action compared to older cycloplegic agents like atropine makes it especially well suited for routine diagnostic exams, where patients need their vision to return to normal within the same day. While temporary blurred vision and light sensitivity are expected parts of the experience, tropicamide has a strong long-term safety record when administered appropriately by a qualified eye care professional. As with any prescription ophthalmic agent, it should only be used under medical supervision, with simple precautions like wearing sunglasses afterward and avoiding driving until vision normalizes.\n\nDisclaimer: This content is for informational purposes only and is not a substitute for professional medical advice. Tropicamide eye drops IP are a prescription medicine and should only be administered by, or under the direct guidance of, a qualified eye care professional.\nManufactured by:\nSteris Healthcare Pvt. Ltd.\nWHO-GMP & ISO Certified Pharmaceutical Manufacturer\nEmail: contact@sterispharma.com | info@sterispharma.com\nContent last reviewed: July 2026", "price": 50.0, "discountamount": 15.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2466, "imageuri": "https://productimages.withfloats.com/actual/6a4cf331dd4ec8cc0aa1b9e4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a4cf331dd4ec8cc0aa1b9e4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-07T12:38:07.8Z", "updatedon": "2026-07-07T12:38:07.8Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tropicamide-eye-drops-ip/2466", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION TRACOPA 1%", "category": "Opthalmology Range", "tags": [ "tropicamide eye drops ip", "tropicamide eye drops ip uses in hindi", "tropicamide eye drops", "tropicamide eye drops uses", "tropicamide eye drops uses in hindi", "tropicamide eye drops price", "tropicamide eye drops bottle", "tropicamide eye drops side effects", "tropicamide eye drops brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a43bee2d208c802be053f9d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg", "description": "Managing type 2 diabetes often requires more than a single medication to achieve long-term blood sugar control. Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a triple-combination prescription medicine formulated to help adults with type 2 diabetes maintain healthy glucose levels when diet, exercise, and single-drug therapy are not enough.\n\nThis advanced combination works through three different mechanisms to improve insulin sensitivity, reduce glucose production by the liver, and enhance the body's natural insulin response after meals. Because of its multi-action approach, it is frequently prescribed by healthcare professionals for patients requiring comprehensive glycemic control.\n\nIf you are searching for Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg, this guide covers everything you need to know—including how it works, benefits, dosage information, side effects, precautions, storage, and frequently asked questions.\n\nWhat is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a prescription oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus. It combines three clinically proven medicines into one convenient tablet to provide better blood sugar management throughout the day.\n\nThe formulation contains:\n\nSitagliptin 100 mg – A DPP-4 inhibitor that increases incretin hormones to improve insulin secretion.\nMetformin Hydrochloride 1000 mg Sustained Release – A biguanide that lowers glucose production by the liver and improves insulin sensitivity.\nPioglitazone 15 mg – A thiazolidinedione that enhances the body's response to insulin.\n\nTogether, these ingredients target multiple causes of high blood sugar, helping patients achieve better diabetes control while reducing the need for multiple separate medications.\n\nHow Does Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg Work?\n\nThis triple-combination tablet works through complementary mechanisms:\n\n1. Sitagliptin\n\nSitagliptin inhibits the DPP-4 enzyme, allowing incretin hormones to remain active longer. These hormones increase insulin release after meals and reduce excess glucagon production.\n\n2. Metformin SR\n\nMetformin Sustained Release decreases glucose production in the liver, reduces intestinal glucose absorption, and improves insulin sensitivity without causing excessive insulin release.\n\n3. Pioglitazone\n\nPioglitazone improves insulin sensitivity in muscle and fat tissues, enabling cells to utilize glucose more effectively.\n\nThe combination helps maintain consistent blood sugar levels throughout the day while lowering both fasting and post-meal glucose.\n\nWhy is This Triple Combination Important?\n\nType 2 diabetes progresses over time, making it difficult for many patients to control blood sugar using a single medication. A triple therapy offers several advantages:\n\nBetter HbA1c reduction\nMultiple mechanisms of action\nReduced insulin resistance\nImproved post-meal glucose control\nLower fasting blood sugar\nSimplified treatment with one tablet\nImproved medication adherence\nReduced need for additional medications\n\nHealthcare providers often prescribe this combination when dual therapy no longer provides adequate glucose control.\n\nKey Benefits of Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\nExcellent Blood Sugar Control\n\nThe medicine helps reduce both fasting and postprandial blood glucose levels effectively.\n\nTriple Mechanism of Action\n\nEach ingredient targets a different pathway involved in diabetes, resulting in more comprehensive glycemic control.\n\nImproved Insulin Sensitivity\n\nPioglitazone increases insulin responsiveness, helping the body utilize glucose more efficiently.\n\nReduced Liver Glucose Production\n\nMetformin decreases glucose release from the liver, preventing unnecessary increases in blood sugar.\n\nSupports Long-Term Diabetes Management\n\nRegular use, alongside lifestyle modifications, contributes to improved HbA1c levels and reduced diabetes-related complications.\n\nConvenient Once-Daily Regimen\n\nCombining three medicines into a single tablet improves treatment convenience and supports better compliance.\n\nWho May Benefit from This Medicine?\n\nHealthcare professionals may prescribe this medication for adults with Type 2 Diabetes who:\n\nHave uncontrolled blood sugar despite dual therapy\nRequire triple oral anti-diabetic therapy\nHave elevated HbA1c levels\nNeed improved insulin sensitivity\nPrefer fewer tablets in their treatment plan\nAre following dietary and exercise recommendations but require additional glucose control\n\nThis medicine is not intended for Type 1 Diabetes or diabetic ketoacidosis.\n\nHow to Take Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\n\nAlways follow your physician's instructions.\n\nGeneral recommendations include:\n\nTake once daily or as prescribed.\nSwallow the tablet whole.\nDo not crush, split, or chew the sustained-release tablet.\nTake with food to reduce stomach discomfort.\nTake it at the same time each day.\nContinue exercising and following a diabetic meal plan.\n\nNever stop treatment without consulting your healthcare provider.\n\nPossible Side Effects\n\nLike all prescription medicines, this combination may cause side effects, although not everyone experiences them.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nDiarrhea\nHeadache\nUpper respiratory infection\nWeight gain\nSwelling of feet or ankles\nMuscle aches\nDizziness\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reaction\nPersistent vomiting\nDifficulty breathing\nSevere abdominal pain\nUnusual fatigue\nYellowing of skin or eyes\nSymptoms of lactic acidosis\nSigns of heart failure, such as rapid weight gain or shortness of breath\nPrecautions Before Using This Medicine\n\nInform your healthcare provider if you have:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer history\nPancreatitis\nSevere dehydration\nAlcohol dependence\nVitamin B12 deficiency\nPlanned surgery or imaging with contrast dye\n\nWomen who are pregnant or breastfeeding should use this medicine only under medical supervision.\n\nDrug Interactions\n\nTell your doctor about all medicines you take, including:\n\nInsulin\nSulfonylureas\nDiuretics\nCorticosteroids\nThyroid medicines\nBlood pressure medicines\nRifampicin\nAlcohol\nCimetidine\nCertain antifungal medicines\n\nProper medication review helps minimize interaction risks.\n\nLifestyle Tips for Better Diabetes Control\n\nMedicine works best when combined with healthy lifestyle habits.\n\nRecommended practices include:\n\nFollow a balanced diabetic diet.\nExercise for at least 30 minutes most days.\nMonitor blood sugar regularly.\nMaintain a healthy body weight.\nStay hydrated.\nAvoid smoking.\nLimit alcohol intake.\nGet regular HbA1c tests.\nManage stress effectively.\nAttend routine medical check-ups.\nStorage Instructions\n\nStore the tablets:\n\nBelow 25°C\nIn a cool, dry place\nAway from moisture and direct sunlight\nIn the original packaging\nOut of reach of children and pets\n\nDo not use expired medicine.\n\nWhy Healthcare Professionals Choose This Triple Combination\n\nDoctors frequently recommend Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg because it addresses multiple aspects of diabetes management in a single formulation. By improving insulin secretion, reducing hepatic glucose production, and enhancing insulin sensitivity, it provides comprehensive glycemic control while simplifying treatment. When combined with a healthy lifestyle and regular medical follow-up, it can support long-term diabetes management and help reduce the risk of complications associated with uncontrolled blood sugar.\n\nConclusion\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is an effective prescription medication designed for adults with Type 2 Diabetes Mellitus who require stronger blood sugar management than single or dual therapy can provide. Its triple-action formula offers improved glycemic control, better insulin utilization, and convenient once-daily dosing. While highly effective, it should always be used under the guidance of a qualified healthcare professional, together with a balanced diet, regular physical activity, and routine blood sugar monitoring for the best long-term outcomes.\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n1. What is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg used for?\n\nIt is prescribed to help adults with Type 2 Diabetes Mellitus control blood sugar when lifestyle changes and other oral medicines do not provide adequate glycemic control.\n\n2. How does this triple-combination tablet work?\n\nIt combines three medicines that increase insulin release after meals, reduce glucose production by the liver, and improve the body's sensitivity to insulin, resulting in better overall blood sugar control.\n\n3. Can this medicine be taken once daily?\n\nYes. Many patients take it once daily, but the exact dosage and timing should always follow the prescribing doctor's instructions.\n\n4. Should I take this tablet with food?\n\nYes. Taking it with meals helps reduce stomach-related side effects associated with metformin and improves tolerability.\n\n5. Can this medicine cure diabetes?\n\nNo. It helps control blood sugar levels but does not cure Type 2 Diabetes. Long-term treatment, healthy eating, exercise, and regular monitoring remain essential.\n\n6. What should I do if I miss a dose?\n\nTake the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not take two doses together to make up for a missed dose.\n\n7. Can this medicine cause low blood sugar?\n\nOn its own, the risk is relatively low. However, the likelihood increases when it is used with insulin or sulfonylurea medicines, or if meals are skipped.\n\n8. Is this medicine safe for patients with kidney disease?\n\nPatients with kidney impairment require medical evaluation before using this medicine, particularly because metformin may not be suitable in severe kidney dysfunction.\n\n9. Can I drink alcohol while taking this medication?\n\nAlcohol intake should be limited or avoided, as excessive consumption may increase the risk of serious side effects, including lactic acidosis.\n\n10. Who should not use Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nIt should not be used without medical advice by individuals with Type 1 Diabetes, diabetic ketoacidosis, severe kidney disease, certain liver conditions, or a history of serious hypersensitivity to any of its ingredients. Always consult your healthcare provider before starting treatment.", "price": 243.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2462, "imageuri": "https://productimages.withfloats.com/actual/6a43bee3de301bd6de277db2.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a43bee3de301bd6de277db2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-30T13:04:34Z", "updatedon": "2026-06-30T13:04:34Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100mg-metformin-hydrochloride-1000mg-sustained-release-pioglitazone-15-mg/2462", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 3D 1000", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }